Denosumab

Details

Files
Generic Name:
Denosumab
Project Status:
Complete
Therapeutic Area:
Osteoporosis, postmenopausal women
Manufacturer:
Amgen Canada Inc.
Call for patient/clinician input open:
Brand Name:
Prolia
Project Line:
Reimbursement Review
Project Number:
SR0208-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Osteoporosis, postmenopausal women
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: